Target intelligence / Profile preview

Simian immunodeficiency virus envelope glycoprotein gp120 (SIV gp120)

Target
SIV gp120
Molecular classification
Viral envelope protein, Glycoprotein, Receptor-binding protein
01

Overview

Simian immunodeficiency virus (SIV) envelope glycoprotein gp120 is the surface subunit of the viral envelope (Env) complex, essential for the infection of host cells [UniProt, https://www.uniprot.org/uniprotkb/P05884/entry]. It is produced by the proteolytic cleavage of the gp160 precursor into gp120 and the transmembrane subunit gp41, which together form trimeric spikes on the virion surface [NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120343/]. Gp120's primary function is to mediate viral attachment by binding to the host CD4 receptor and a chemokine co-receptor, typically CCR5, which triggers conformational changes in gp41 to initiate membrane fusion [Wikipedia, https://en.wikipedia.org/wiki/Envelope_glycoprotein_GP120]. As the most exposed viral protein, it is the primary target for neutralizing antibodies and a central focus for vaccine and entry inhibitor development [PubMed, https://pubmed.ncbi.nlm.nih.gov/26324120/]. However, gp120 employs sophisticated evasion strategies, including extensive N-linked glycosylation (the glycan shield) and high sequence variability in its five variable loops (V1-V5), which present significant challenges for therapeutic targeting [NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403475/]. In research models, SIV gp120 serves as a vital surrogate for understanding HIV-1 pathogenesis and testing novel interventions like broadly neutralizing antibodies and attachment inhibitors [Science, https://www.science.org/doi/10.1126/science.aag1619].

Other names
SIV gp120Surface protein gp120SU proteinEnv gp120gp120 subunit of Env
02

Mechanism of action

Attachment inhibition, Entry inhibition, Neutralization, Receptor mimicry

03

Biological functions

Viral attachmentReceptor binding (CD4)Co-receptor binding (CCR5/CXCR4)Immune evasionMembrane fusion triggeringApoptosis induction
04

Disease associations

Simian immunodeficiency virus infectionAcquired immunodeficiency syndrome (AIDS)
05

Safety considerations

Antigenic drift (high mutation rate)Glycan shieldingConformational flexibilityAntibody-dependent enhancement (ADE)Target-mediated drug disposition (TMDD)
06

Interacting drugs

Fostemsavir

6 more in the full profile.

07

Biomarkers

Viral load (SIV RNA)CD4+ T-cell countAnti-gp120 antibody titersProviral DNA intactness

Beyond the preview

Go deeper on Simian immunodeficiency virus envelope glycoprotein gp120 (SIV gp120).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Simian immunodeficiency virus envelope glycoprotein gp120 (SIV gp120).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call